Stockreport

VYNE Therapeutics receives FDA approval for trial of VYN202 [Yahoo! Finance]

VYNE Therapeutics Inc.  (VYNE) 
PDF The double-blind, placebo-controlled, first-in-human trial will assess VYN202's safety, pharmacokinetics, pharmacodynamics and efficacy in both single ascending-dose (S [Read more]